stem cells in Europe
Questions ? WhatsApp: +447778936902 , +33745637397, +34670491885 e-mail: head_office@nbscience.com e-mail: head_office@nbscience.com
Stem Cell Therapy of Epilepsy . Epilepsy as one of the most common neurological disorders affects more than 50 million people worldwide with a higher prevalence rate in low-income countries. Excessive electrical discharges in neurons following neural cell damage or loss cause recurrent seizures. One of the most common and Read more…
Muscular dystrophy Lgmd2a stem cell therapy Since 1998, we have been developing complex protocols for stem cell treatment of muscular dystrophy in order to overcome the limitations of traditional therapy. In our protocols, stem cells are combined with specialized therapy for muscular dystrophy, which not only focuses on helping the Read more…
STEM CELL THERAPY Stem cells have shown tremendous promise for understanding and treating a range of intractable diseases, injuries and other health-related conditions. Clinical trials involving stem cells are underway for many conditions, and each day moves researchers closer to another medical breakthrough. Stem cells have demonstrated encouraging potential as Read more…
Attention Deficit Hyperactivity Disorder ADHD Stem Cells Therapy in Europe Stem cell therapy in Europe results in several remarkable improvements in various symptoms of ADHD Hyperactivity and engaging in stereotypical and repetitive motor mannerisms decrease significantly. Sensory and motor functioning improves. Improvements are seen in concentration and the attention span Read more…
В чем разница между эмбриональными стволовыми клетками, эмбриональными стволовыми клетками и мезенхимальными стволовыми клетками? Вопросы? head_office@nbscience.com
Medical conferences 2024 1) Congress of Oncologists and Radiologists 26-27 May 2) World Health Day 07-08 April 2024 3) Current issues of cardiology 12 May 2024 4) Psychiatric care 14-15 April 2024 5) Urgent cardiovascular conditions: multidisciplinary approach 02-03 June 2024 6) Treatment of diseases of the nervous system 08-09 September Read more…
Autism stem cell therapy Generally, parents notice signs of Autism very early before age 2 or 3. Mostly, motor milestones develop normally but delays can be observed. Parents might notice delays in speech and interactions or sometimes the speech develops but regresses thereafter. As brain functioning is heavily involved in Read more…
